APA (7th ed.) Citation

Jimbu, L., Mesaros, O., Neaga, A., Nanut, A. M., Tomuleasa, C., Dima, D., . . . Zdrenghea, M. (2021). The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG.

Chicago Style (17th ed.) Citation

Jimbu, Laura, Oana Mesaros, Alexandra Neaga, Ana Maria Nanut, Ciprian Tomuleasa, Delia Dima, Corina Bocsan, and Mihnea Zdrenghea. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.

MLA (8th ed.) Citation

Jimbu, Laura, et al. The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia. MDPI AG, 2021.